Carisma Therapeutics股票讨论区

$Carisma Therapeutics(CARM.US)$
NEWS
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
Carisma Therapeutics (Nasdaq: CARM) has dosed the first patient in its Phase 1 clinical trial of CT-0525, a novel CAR-Monocyte cellular therapy targeting HER2-overexpressing solid tumors. This marks the first human trial for CAR-Monocytes in a solid tumor setting. Initial data is anticipated by year-end 2024. The trial, open-label in ...

$Carisma Therapeutics(CARM.US)$
NEWS
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

$Carisma Therapeutics(CARM.US)$ is this a good stock?

$iSpecimen(ISPC.US)$ sell
$Carisma Therapeutics(CARM.US)$ buy 🏆🔥💴

$Carisma Therapeutics(CARM.US)$ buy🏆🔥🔥🔥🔥

$Carisma Therapeutics(CARM.US)$ Carisma Therapeutics Has Nominated Its First Lead Candidate Under The Collaboration With Moderna That Will Target An Antigen Present On A Solid Tumor

$Carisma Therapeutics(CARM.US)$
FDA news but dipping ?